The Developing Countries Vaccine Manufacturers Network (DCVMN) was established in the year 2000, sharing the vision of protecting all people against known and emerging infectious diseases globally by increasing the production of high-quality vaccines in developing countries. DCVMN is a voluntary alliance of over 40 vaccine manufacturers from 15 developing countries, firmly engaged in innovation, research, development, manufacturing, and supply of over 60 different types of high-quality vaccines, to 170 countries striving to enable equitable access to vaccines. It works to strengthen vaccine manufacturers through the provision of advocacy, professional training programs on technological and production improvements, and acting as a liaison to foster partnerships and funding. DCVMN also encourages technology transfer initiatives and educates the public about the availability of safe, effective and affordable vaccines for all people. 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁𝘀: The Developing Countries Vaccine Manufacturers Network (DCVMN) stands ready to fully collaborate with the Access to COVID Tools (ACT) Accelerator initiative. Collectively, ~60% of the global production of COVID-19 vaccines are from DCVMN member manufacturers. The Network is able to stimulate early cooperation between vaccine developers, production and supply towards the rollout of vaccination, enabling equitable access to COVID-19 vaccines. All members of DCVMs have a role to play - big or small - in contributing to the scale-up and supply of effective COVID-19 vaccines. DCVMN members, with vaccine manufacturing, filling, packaging and distribution capabilities, are supporting this call, to ensure vaccines reach populations in every corner of the world without undue delay.